Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital

Aim: The present study was designed to investigate the microbiology of choledochal bile of patients with cholangitis and choledocholithiasis. Methods: We identified and determined the antimicrobial susceptibility of bacteria isolated in the bile of patients with cholangitis and choledocholithiasis d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of gastroenterology and hepatology 2003-03, Vol.18 (3), p.333-336
Hauptverfasser: FLORES, CRISTINA, MAGUILNIK, ISMAEL, HADLICH, EVERTON, GOLDANI, LUCIANO Z
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 336
container_issue 3
container_start_page 333
container_title Journal of gastroenterology and hepatology
container_volume 18
creator FLORES, CRISTINA
MAGUILNIK, ISMAEL
HADLICH, EVERTON
GOLDANI, LUCIANO Z
description Aim: The present study was designed to investigate the microbiology of choledochal bile of patients with cholangitis and choledocholithiasis. Methods: We identified and determined the antimicrobial susceptibility of bacteria isolated in the bile of patients with cholangitis and choledocholithiasis diagnosed by endoscopic retrograde cholangiopancreatography (ERCP). Results: Nineteen (82.6%) of 23 patients with choledocholithiasis had positive bile cultures. A single agent was detected in 11 patients (57.9%), while a mixed growth, with pathogens ranging from two to three species, were seen in eight patients (42.1%). Patients with clinical manifestations of cholangitis had significantly higher counts of colonies per mL of bile (> 105 cfu/mL).The predominant Gram‐negative aerobic bacteria isolated were Escherichia coli (9, 31.0%), Klebsiella pneumoniae (5, 17.2%), Enterobacter cloacae (2, 6.9%), Pantoea agglomerans (1, 3.4%), and Pseudomonas aeruginosa (1, 3.4%). The predominant Gram‐positive bacteria were Enterococcus faecalis (5, 17.2%) and Streptococcus sp. (5, 17.2%). Bacteroides fragilis was isolated in one patient with mixed growth. All Gram‐positive bacteria isolated in bile were sensitive to ampicillin, and all Gram‐negative bacteria isolated were sensitive to gentamicin with a minimum inhibitory concentration (CIM90) ranging from 0.5 to 1.0‐µg/mL. Gram‐negative bacteria were also sensitive to imipenem, fluorquinolones, second and third generation cephalosporins. Although all five isolates of E. faecalis were sensitive to ampicillin, two of five (40%) E. faecalis isolates demonstrated high levels of resistance to gentamicin. Conclusion: E. coli, K. pneumoniae, E. faecalis and Streptoccocus sp. were the most common bacteria isolated in the bile of patients with cholangitis and choledocholithiasis, which were sensitive to a simple therapeutic regimen, such as the combination of ampicilin and gentamicin.
doi_str_mv 10.1046/j.1440-1746.2003.02971.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73064754</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73064754</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4331-f8e1e4698d02e5e6cf6950a3220bbdd930f9068e31ccc0249f79a24f8217fc3c3</originalsourceid><addsrcrecordid>eNqNkE1vEzEQhi0EoqHwF5AvcNvt-GO96wMHlELaKsAFxNHyem3i4MRh7ajJv8dLoubKybbmeT0zD0KYQE2Ai5t1TTiHirRc1BSA1UBlS-rDMzR7KjxHM-hIU0lG5BV6ldIaADi0zUt0RagA1jAxQ_aLN2PsfQzx1xFHh80qBjtEs9IB9z5Y7Ld4p7O325zwo8-rCxFDeXqdfMJ62Pic7YBzxBpnO2avxyNexbTzWYfX6IXTIdk35_Ma_fj86fv8rlp-W9zPPy4rwxkjlesssVzIbgBqGyuME7IBzSiFvh8GycBJEJ1lxBgDlEvXSk256yhpnWGGXaP3p393Y_yztymrjU_GhqC3Nu6TahkI3ja8gN0JLMunNFqndqPflJEVATUpVms1mVSTSTUpVv8Uq0OJvj332PcbO1yCZ6cFeHcGdDI6uFFvjU8XjotO8K4r3IcT91g0H_97APWwuJtuJV-d8j5le3jK6_G3Ei1rG_Xz60Ld8tv5fMke1IL9BRt2p5g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73064754</pqid></control><display><type>article</type><title>Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>FLORES, CRISTINA ; MAGUILNIK, ISMAEL ; HADLICH, EVERTON ; GOLDANI, LUCIANO Z</creator><creatorcontrib>FLORES, CRISTINA ; MAGUILNIK, ISMAEL ; HADLICH, EVERTON ; GOLDANI, LUCIANO Z</creatorcontrib><description>Aim: The present study was designed to investigate the microbiology of choledochal bile of patients with cholangitis and choledocholithiasis. Methods: We identified and determined the antimicrobial susceptibility of bacteria isolated in the bile of patients with cholangitis and choledocholithiasis diagnosed by endoscopic retrograde cholangiopancreatography (ERCP). Results: Nineteen (82.6%) of 23 patients with choledocholithiasis had positive bile cultures. A single agent was detected in 11 patients (57.9%), while a mixed growth, with pathogens ranging from two to three species, were seen in eight patients (42.1%). Patients with clinical manifestations of cholangitis had significantly higher counts of colonies per mL of bile (&gt; 105 cfu/mL).The predominant Gram‐negative aerobic bacteria isolated were Escherichia coli (9, 31.0%), Klebsiella pneumoniae (5, 17.2%), Enterobacter cloacae (2, 6.9%), Pantoea agglomerans (1, 3.4%), and Pseudomonas aeruginosa (1, 3.4%). The predominant Gram‐positive bacteria were Enterococcus faecalis (5, 17.2%) and Streptococcus sp. (5, 17.2%). Bacteroides fragilis was isolated in one patient with mixed growth. All Gram‐positive bacteria isolated in bile were sensitive to ampicillin, and all Gram‐negative bacteria isolated were sensitive to gentamicin with a minimum inhibitory concentration (CIM90) ranging from 0.5 to 1.0‐µg/mL. Gram‐negative bacteria were also sensitive to imipenem, fluorquinolones, second and third generation cephalosporins. Although all five isolates of E. faecalis were sensitive to ampicillin, two of five (40%) E. faecalis isolates demonstrated high levels of resistance to gentamicin. Conclusion: E. coli, K. pneumoniae, E. faecalis and Streptoccocus sp. were the most common bacteria isolated in the bile of patients with cholangitis and choledocholithiasis, which were sensitive to a simple therapeutic regimen, such as the combination of ampicilin and gentamicin.</description><identifier>ISSN: 0815-9319</identifier><identifier>EISSN: 1440-1746</identifier><identifier>DOI: 10.1046/j.1440-1746.2003.02971.x</identifier><identifier>PMID: 12603536</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Pty</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Ampicillin - therapeutic use ; Anti-Bacterial Agents - therapeutic use ; antimicrobial susceptibility ; bacteria ; bile ; Biological and medical sciences ; Brazil ; Cephalosporins - therapeutic use ; Cholangiopancreatography, Endoscopic Retrograde ; choledocholithiasis ; Common Bile Duct - diagnostic imaging ; Common Bile Duct - microbiology ; Common Bile Duct - pathology ; Disease Susceptibility - diagnosis ; Disease Susceptibility - microbiology ; Disease Susceptibility - therapy ; Female ; Gallstones - diagnosis ; Gallstones - microbiology ; Gallstones - therapy ; Gastroenterology. Liver. Pancreas. Abdomen ; Gentamicins - therapeutic use ; Gram-Negative Bacterial Infections - diagnosis ; Gram-Negative Bacterial Infections - microbiology ; Gram-Negative Bacterial Infections - therapy ; Gram-Positive Bacterial Infections - diagnosis ; Gram-Positive Bacterial Infections - microbiology ; Gram-Positive Bacterial Infections - therapy ; Humans ; Imipenem - therapeutic use ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Microbial Sensitivity Tests ; Middle Aged ; Other diseases. Semiology ; Patient Admission ; Penicillins - therapeutic use ; Treatment Outcome ; Tropical medicine</subject><ispartof>Journal of gastroenterology and hepatology, 2003-03, Vol.18 (3), p.333-336</ispartof><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4331-f8e1e4698d02e5e6cf6950a3220bbdd930f9068e31ccc0249f79a24f8217fc3c3</citedby><cites>FETCH-LOGICAL-c4331-f8e1e4698d02e5e6cf6950a3220bbdd930f9068e31ccc0249f79a24f8217fc3c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1440-1746.2003.02971.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1440-1746.2003.02971.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14686488$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12603536$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FLORES, CRISTINA</creatorcontrib><creatorcontrib>MAGUILNIK, ISMAEL</creatorcontrib><creatorcontrib>HADLICH, EVERTON</creatorcontrib><creatorcontrib>GOLDANI, LUCIANO Z</creatorcontrib><title>Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital</title><title>Journal of gastroenterology and hepatology</title><addtitle>J Gastroenterol Hepatol</addtitle><description>Aim: The present study was designed to investigate the microbiology of choledochal bile of patients with cholangitis and choledocholithiasis. Methods: We identified and determined the antimicrobial susceptibility of bacteria isolated in the bile of patients with cholangitis and choledocholithiasis diagnosed by endoscopic retrograde cholangiopancreatography (ERCP). Results: Nineteen (82.6%) of 23 patients with choledocholithiasis had positive bile cultures. A single agent was detected in 11 patients (57.9%), while a mixed growth, with pathogens ranging from two to three species, were seen in eight patients (42.1%). Patients with clinical manifestations of cholangitis had significantly higher counts of colonies per mL of bile (&gt; 105 cfu/mL).The predominant Gram‐negative aerobic bacteria isolated were Escherichia coli (9, 31.0%), Klebsiella pneumoniae (5, 17.2%), Enterobacter cloacae (2, 6.9%), Pantoea agglomerans (1, 3.4%), and Pseudomonas aeruginosa (1, 3.4%). The predominant Gram‐positive bacteria were Enterococcus faecalis (5, 17.2%) and Streptococcus sp. (5, 17.2%). Bacteroides fragilis was isolated in one patient with mixed growth. All Gram‐positive bacteria isolated in bile were sensitive to ampicillin, and all Gram‐negative bacteria isolated were sensitive to gentamicin with a minimum inhibitory concentration (CIM90) ranging from 0.5 to 1.0‐µg/mL. Gram‐negative bacteria were also sensitive to imipenem, fluorquinolones, second and third generation cephalosporins. Although all five isolates of E. faecalis were sensitive to ampicillin, two of five (40%) E. faecalis isolates demonstrated high levels of resistance to gentamicin. Conclusion: E. coli, K. pneumoniae, E. faecalis and Streptoccocus sp. were the most common bacteria isolated in the bile of patients with cholangitis and choledocholithiasis, which were sensitive to a simple therapeutic regimen, such as the combination of ampicilin and gentamicin.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Ampicillin - therapeutic use</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>antimicrobial susceptibility</subject><subject>bacteria</subject><subject>bile</subject><subject>Biological and medical sciences</subject><subject>Brazil</subject><subject>Cephalosporins - therapeutic use</subject><subject>Cholangiopancreatography, Endoscopic Retrograde</subject><subject>choledocholithiasis</subject><subject>Common Bile Duct - diagnostic imaging</subject><subject>Common Bile Duct - microbiology</subject><subject>Common Bile Duct - pathology</subject><subject>Disease Susceptibility - diagnosis</subject><subject>Disease Susceptibility - microbiology</subject><subject>Disease Susceptibility - therapy</subject><subject>Female</subject><subject>Gallstones - diagnosis</subject><subject>Gallstones - microbiology</subject><subject>Gallstones - therapy</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gentamicins - therapeutic use</subject><subject>Gram-Negative Bacterial Infections - diagnosis</subject><subject>Gram-Negative Bacterial Infections - microbiology</subject><subject>Gram-Negative Bacterial Infections - therapy</subject><subject>Gram-Positive Bacterial Infections - diagnosis</subject><subject>Gram-Positive Bacterial Infections - microbiology</subject><subject>Gram-Positive Bacterial Infections - therapy</subject><subject>Humans</subject><subject>Imipenem - therapeutic use</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Middle Aged</subject><subject>Other diseases. Semiology</subject><subject>Patient Admission</subject><subject>Penicillins - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Tropical medicine</subject><issn>0815-9319</issn><issn>1440-1746</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1vEzEQhi0EoqHwF5AvcNvt-GO96wMHlELaKsAFxNHyem3i4MRh7ajJv8dLoubKybbmeT0zD0KYQE2Ai5t1TTiHirRc1BSA1UBlS-rDMzR7KjxHM-hIU0lG5BV6ldIaADi0zUt0RagA1jAxQ_aLN2PsfQzx1xFHh80qBjtEs9IB9z5Y7Ld4p7O325zwo8-rCxFDeXqdfMJ62Pic7YBzxBpnO2avxyNexbTzWYfX6IXTIdk35_Ma_fj86fv8rlp-W9zPPy4rwxkjlesssVzIbgBqGyuME7IBzSiFvh8GycBJEJ1lxBgDlEvXSk256yhpnWGGXaP3p393Y_yztymrjU_GhqC3Nu6TahkI3ja8gN0JLMunNFqndqPflJEVATUpVms1mVSTSTUpVv8Uq0OJvj332PcbO1yCZ6cFeHcGdDI6uFFvjU8XjotO8K4r3IcT91g0H_97APWwuJtuJV-d8j5le3jK6_G3Ei1rG_Xz60Ld8tv5fMke1IL9BRt2p5g</recordid><startdate>200303</startdate><enddate>200303</enddate><creator>FLORES, CRISTINA</creator><creator>MAGUILNIK, ISMAEL</creator><creator>HADLICH, EVERTON</creator><creator>GOLDANI, LUCIANO Z</creator><general>Blackwell Science Pty</general><general>Blackwell Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200303</creationdate><title>Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital</title><author>FLORES, CRISTINA ; MAGUILNIK, ISMAEL ; HADLICH, EVERTON ; GOLDANI, LUCIANO Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4331-f8e1e4698d02e5e6cf6950a3220bbdd930f9068e31ccc0249f79a24f8217fc3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Ampicillin - therapeutic use</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>antimicrobial susceptibility</topic><topic>bacteria</topic><topic>bile</topic><topic>Biological and medical sciences</topic><topic>Brazil</topic><topic>Cephalosporins - therapeutic use</topic><topic>Cholangiopancreatography, Endoscopic Retrograde</topic><topic>choledocholithiasis</topic><topic>Common Bile Duct - diagnostic imaging</topic><topic>Common Bile Duct - microbiology</topic><topic>Common Bile Duct - pathology</topic><topic>Disease Susceptibility - diagnosis</topic><topic>Disease Susceptibility - microbiology</topic><topic>Disease Susceptibility - therapy</topic><topic>Female</topic><topic>Gallstones - diagnosis</topic><topic>Gallstones - microbiology</topic><topic>Gallstones - therapy</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gentamicins - therapeutic use</topic><topic>Gram-Negative Bacterial Infections - diagnosis</topic><topic>Gram-Negative Bacterial Infections - microbiology</topic><topic>Gram-Negative Bacterial Infections - therapy</topic><topic>Gram-Positive Bacterial Infections - diagnosis</topic><topic>Gram-Positive Bacterial Infections - microbiology</topic><topic>Gram-Positive Bacterial Infections - therapy</topic><topic>Humans</topic><topic>Imipenem - therapeutic use</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Middle Aged</topic><topic>Other diseases. Semiology</topic><topic>Patient Admission</topic><topic>Penicillins - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Tropical medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FLORES, CRISTINA</creatorcontrib><creatorcontrib>MAGUILNIK, ISMAEL</creatorcontrib><creatorcontrib>HADLICH, EVERTON</creatorcontrib><creatorcontrib>GOLDANI, LUCIANO Z</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FLORES, CRISTINA</au><au>MAGUILNIK, ISMAEL</au><au>HADLICH, EVERTON</au><au>GOLDANI, LUCIANO Z</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital</atitle><jtitle>Journal of gastroenterology and hepatology</jtitle><addtitle>J Gastroenterol Hepatol</addtitle><date>2003-03</date><risdate>2003</risdate><volume>18</volume><issue>3</issue><spage>333</spage><epage>336</epage><pages>333-336</pages><issn>0815-9319</issn><eissn>1440-1746</eissn><abstract>Aim: The present study was designed to investigate the microbiology of choledochal bile of patients with cholangitis and choledocholithiasis. Methods: We identified and determined the antimicrobial susceptibility of bacteria isolated in the bile of patients with cholangitis and choledocholithiasis diagnosed by endoscopic retrograde cholangiopancreatography (ERCP). Results: Nineteen (82.6%) of 23 patients with choledocholithiasis had positive bile cultures. A single agent was detected in 11 patients (57.9%), while a mixed growth, with pathogens ranging from two to three species, were seen in eight patients (42.1%). Patients with clinical manifestations of cholangitis had significantly higher counts of colonies per mL of bile (&gt; 105 cfu/mL).The predominant Gram‐negative aerobic bacteria isolated were Escherichia coli (9, 31.0%), Klebsiella pneumoniae (5, 17.2%), Enterobacter cloacae (2, 6.9%), Pantoea agglomerans (1, 3.4%), and Pseudomonas aeruginosa (1, 3.4%). The predominant Gram‐positive bacteria were Enterococcus faecalis (5, 17.2%) and Streptococcus sp. (5, 17.2%). Bacteroides fragilis was isolated in one patient with mixed growth. All Gram‐positive bacteria isolated in bile were sensitive to ampicillin, and all Gram‐negative bacteria isolated were sensitive to gentamicin with a minimum inhibitory concentration (CIM90) ranging from 0.5 to 1.0‐µg/mL. Gram‐negative bacteria were also sensitive to imipenem, fluorquinolones, second and third generation cephalosporins. Although all five isolates of E. faecalis were sensitive to ampicillin, two of five (40%) E. faecalis isolates demonstrated high levels of resistance to gentamicin. Conclusion: E. coli, K. pneumoniae, E. faecalis and Streptoccocus sp. were the most common bacteria isolated in the bile of patients with cholangitis and choledocholithiasis, which were sensitive to a simple therapeutic regimen, such as the combination of ampicilin and gentamicin.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Pty</pub><pmid>12603536</pmid><doi>10.1046/j.1440-1746.2003.02971.x</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0815-9319
ispartof Journal of gastroenterology and hepatology, 2003-03, Vol.18 (3), p.333-336
issn 0815-9319
1440-1746
language eng
recordid cdi_proquest_miscellaneous_73064754
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Aged
Aged, 80 and over
Ampicillin - therapeutic use
Anti-Bacterial Agents - therapeutic use
antimicrobial susceptibility
bacteria
bile
Biological and medical sciences
Brazil
Cephalosporins - therapeutic use
Cholangiopancreatography, Endoscopic Retrograde
choledocholithiasis
Common Bile Duct - diagnostic imaging
Common Bile Duct - microbiology
Common Bile Duct - pathology
Disease Susceptibility - diagnosis
Disease Susceptibility - microbiology
Disease Susceptibility - therapy
Female
Gallstones - diagnosis
Gallstones - microbiology
Gallstones - therapy
Gastroenterology. Liver. Pancreas. Abdomen
Gentamicins - therapeutic use
Gram-Negative Bacterial Infections - diagnosis
Gram-Negative Bacterial Infections - microbiology
Gram-Negative Bacterial Infections - therapy
Gram-Positive Bacterial Infections - diagnosis
Gram-Positive Bacterial Infections - microbiology
Gram-Positive Bacterial Infections - therapy
Humans
Imipenem - therapeutic use
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Microbial Sensitivity Tests
Middle Aged
Other diseases. Semiology
Patient Admission
Penicillins - therapeutic use
Treatment Outcome
Tropical medicine
title Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T12%3A43%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microbiology%20of%20choledochal%20bile%20in%20patients%20with%20choledocholithiasis%20admitted%20to%20a%20tertiary%20hospital&rft.jtitle=Journal%20of%20gastroenterology%20and%20hepatology&rft.au=FLORES,%20CRISTINA&rft.date=2003-03&rft.volume=18&rft.issue=3&rft.spage=333&rft.epage=336&rft.pages=333-336&rft.issn=0815-9319&rft.eissn=1440-1746&rft_id=info:doi/10.1046/j.1440-1746.2003.02971.x&rft_dat=%3Cproquest_cross%3E73064754%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73064754&rft_id=info:pmid/12603536&rfr_iscdi=true